Levetiracetam Granules(Poly Pharm)

左乙拉西坦颗粒(普利制药)

Report date: 2025/09/23 09:59:43

Base Information

Drug NameLevetiracetam Granules(Poly Pharm)
Drug Alias NameLevetiracetamum左旋乙拉西坦Levetiracetam IR左乙拉西坦颗粒(改良型)Levetiracetam XR +[7
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSynaptic vesicle glycoprotein 2A modulators
TargetsSynaptic vesicle glycoprotein 2A
Therapy Area/IndicationsEpilepsies, Partial
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusDiscontinued (NDA/BLA)
Highest Status in ChinaDiscontinued
Originator CompaniesHainan Poly Pharm Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesHainan Poly Pharm Co Ltd
Active IndicationsN/A
Inactive IndicationsEpilepsies, Partial

Other Information

ATC CodeN/A